Pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015, as amended from time to time read with Company''s Code of Conduct to regulate, monitor and report the trading of equity ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
ANG Lifesciences India Ltd has announced the closure of its trading window for insiders, designated persons, and their immediate relatives starting 1st April 2025. The window will remain shut until 48 hours after the declaration of audited standalone and consolidated financial results for the quarter and full year ending 31st March 2025. The date of the board meeting to consider these results will be communicated separately. This is a standard compliance action under SEBI's Insider Trading Regulations and the company's internal code of conduct. It restricts designated employees and insiders from trading in the company's shares during a sensitive period around the financial results announcement.
No direct impact on shareholders. This is a routine regulatory filing that signals upcoming audited FY25 results, which could be a key catalyst for the stock once the board meeting date is announced.